INMD logo

INMODE LTD

INMDNASDAQ
πŸ† #2559 by market capEarnings Nov 11 Β· PreUS Equity
β€”β€”
Quote unavailable
πŸ””
Track INMD
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$769M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-6.7%
Declining
πŸ“ŠGross Margin
76.5%
High
πŸ’΅FCF Margin
22.0%
Strong
βš–οΈP/S Ratio
2.0x
Cheap
Otter Score
72
Strong
No chart data available for INMD.

Trading Snapshot

Day Range
β€”
52-Week Range
$12.72 – $16.67
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
57.5M
Next Earnings
2026-11-11

Fundamentals Snapshot

Annual Revenue
$370M
Last Q Revenue
$96M
P/E Ratio
9.9
P/S Ratio
2.0x
EPS (TTM)
$1.23
Dividend Yield
β€”
Dilution (1yr)
βˆ’12.0%
INMD logo

INMODE LTD

INMD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$370Mβ–Ό βˆ’6.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
78.5%β–Ό βˆ’2.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$85Mβ–Ό βˆ’24.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$84Mβ–Ό βˆ’36.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
64.1Mβ–Ό βˆ’12.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$289Mβ–² +$142M YoY
StockOtter Β· stockotter.space

About INMODE LTD

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

News unavailable.